Friday, 28 August 2020

Cholesterol drug combinations could cut health risk for European patients

New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.



source https://www.pharmatutor.org/pharma-news/2020/cholesterol-drug-combinations-could-cut-health-risk-for-european-patients

No comments:

Post a Comment

Pharmaceutical Industry and pharma / Life Sciences institute openings 2025

  Intas Pharma Walk in Drive for M.Pharm, B.Pharm | Multiple Posts M.Pharma / B.Pharma. Injectable/Parenteral/Sterile - Aseptic, Manufacturi...